Resihance Tablet (Regorafenib)
Regorafenib Tablet, sold under the brand name Resihance, or Stivarga, is a medication used in the treatment of certain types of cancer.
Introduction of Resihance Tablet (Regorafenib)
Regorafenib Tablet, sold under the brand name Resihance, is an oral medication that belongs to the class of drugs known as kinase inhibitors. It is primarily used in the treatment of certain types of cancer. Regorafenib works by blocking the action of certain proteins in cancer cells, which helps to slow down or stop the growth and spread of the tumor. Regorafenib Tablet (Resihance) is a powerful Anti-Cancer and Life-Saving Drug that has shown efficacy in the treatment of various types of cancer. However, it is crucial to balance its potential benefits with the risks associated with its use. Adherence to precautions, awareness of drug interactions, and prompt reporting of any side effects are vital to ensure the safe and effective use of Regorafenib in cancer therapy. Stivarga is the brand name for the generic drug Regorafenib. Both Stivarga and Regorafenib Tablet (Resihance) contain the same active ingredient and are used for the same indications mentioned above. Stivarga is marketed by Bayer HealthCare Pharmaceuticals Inc. and is available in various countries around the world.
Dosage Information:
The dosage of Regorafenib Tablet may vary depending on the specific cancer being treated, the patient's overall health, and other factors. It is essential to follow the prescribed dosage and instructions provided by your healthcare professional. Typically, Regorafenib is taken once a day, with or without food, in the form of tablets that are swallowed whole.
At 1mgstore.com Regorafenib Tablet Price:
The price of Regorafenib Tablet can vary depending on several factors, including the country, region, pharmacy, and any applicable insurance coverage or discounts. It is recommended to see the options to obtain accurate and up-to-date pricing details.
Regorafenib Tablet for Cancer:
Regorafenib Tablet is primarily used in the treatment of certain types of cancer, including colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma (HCC). It is an important therapeutic option for patients who have not responded to other treatments or whose cancer has progressed despite prior therapies. Regorafenib helps to inhibit the growth of cancer cells and improve overall survival rates.
Regorafenib Tablet Brand Name:
Regorafenib Tablet is sold under the brand name Resihance. The brand name may vary in different countries, as different pharmaceutical companies may market the medication under different names. It is important to check the specific brand name used in your country or region.
Regorafenib Tablet Manufacturer:
Resihance (Regorafenib Tablet) is manufactured by Bayer HealthCare Pharmaceuticals Inc., a global pharmaceutical company. Bayer is known for its extensive research and development in the field of oncology and the production of innovative medications to address the needs of patients with cancer.
Some of the Key Safety Advice to be noticed while using Resihance Tablet (Regorafenib)
Medical History: Before starting treatment with Regorafenib, inform your healthcare provider about your complete medical history, including any pre-existing conditions, such as liver disease, heart problems, bleeding disorders, or hypertension.
Pregnancy and Breastfeeding: Regorafenib/Stivarga can cause harm to the unborn baby, so it should not be used during pregnancy. It is also not recommended for use while breastfeeding, as it may pass into breast milk and harm the nursing infant. Consult your healthcare provider for guidance on the appropriate use of contraceptives during treatment.
Liver Function: Regorafenib (Resihance) can affect liver function, and regular monitoring of liver function tests is necessary during treatment. Inform your doctor if you have a history of liver disease or if you experience symptoms such as yellowing of the skin or eyes, abdominal pain, dark urine, or unusual fatigue.
Hypertension: Regorafenib can cause an increase in blood pressure. Regular monitoring of blood pressure is essential during treatment, and appropriate management strategies may be recommended by your healthcare provider.
Regorafenib Tablet is approved for the treatment of:
Colorectal cancer: Regorafenib is used in patients who have previously received chemotherapy for colorectal cancer that has spread to other parts of the body. It helps to delay the progression of the disease and extend survival.
Gastrointestinal stromal tumors (GIST): Regorafenib/Stivarga is used in patients with GIST that cannot be surgically removed or have spread to other parts of the body. It is prescribed when other treatments have not been effective.
Hepatocellular carcinoma (HCC): Regorafenib (Resihance) is used in patients with HCC who have been previously treated with sorafenib, another cancer medication. It is prescribed to slow down the progression of the disease.
Regorafenib Tablet should only be taken under the supervision of a qualified healthcare professional experienced in the use of anticancer medications.
Key Secondary Effects Must be Noticed while using Resihance Tablet (Regorafenib)
Gastrointestinal Side Effects: The most common side effects of Regorafenib include diarrhea, nausea, vomiting, abdominal pain, and loss of appetite. These gastrointestinal effects can be severe and may require supportive care or dose adjustments.
Fatigue and Weakness: Regorafenib can cause fatigue, weakness, and general malaise. It is important to rest and conserve energy during treatment and to inform your healthcare provider if these symptoms become debilitating.
Hypertension: Regorafenib may increase blood pressure, and regular monitoring is necessary. If you experience severe or persistent high blood pressure, notify your healthcare provider promptly.
Hand-Foot Skin Reaction: Regorafenib/Stivarga can cause a skin reaction called hand-foot syndrome, characterized by redness, swelling, pain, and blistering on the palms of the hands and soles of the feet. Good skin care practices, including moisturizing and avoiding excessive pressure or friction, may help manage this side effect.
Bleeding: Regorafenib (Resihance) can increase the risk of bleeding, and it is important to notify your doctor if you experience any signs of bleeding, such as easy bruising, prolonged bleeding from cuts, or blood in urine or stool.
Wound Healing Complications: Regorafenib may impair wound healing. Inform your healthcare provider if you have any scheduled surgical procedures or if you experience delayed wound healing during treatment.
Frequently Asked Concerns about Regorafenib Tablet (Resihance)
Q: Can Regorafenib Tablet (Resihance) be taken with food?
A: Yes, Regorafenib Tablet can be taken with or without food. However, it is recommended to follow the specific instructions provided by your healthcare professional or refer to the product information leaflet.
Q: Is it safe to consume alcohol while taking Regorafenib Tablet?
A: It is generally advised to avoid alcohol consumption while on Regorafenib treatment. Alcohol can worsen certain side effects, such as liver toxicity and gastrointestinal symptoms, and may also interfere with the efficacy of the medication.
Q: Can Regorafenib Tablet/Stivarga be used in pediatric patients?
A: The safety and effectiveness of Regorafenib Tablet have not been established in pediatric populations. This medication is typically indicated for use in adult patients, and its use in children or adolescents should be discussed with a pediatric oncology specialist.
Q: Are there any specific monitoring requirements during Regorafenib treatment?
A: Yes, regular monitoring of liver function tests and blood pressure is recommended while taking Regorafenib Tablet. Your healthcare provider may also order additional tests, such as complete blood counts and electrolyte levels, to assess your overall health and response to the medication.
Q: Can Regorafenib Tablet interact with herbal supplements?
A: Yes, Regorafenib can interact with herbal supplements, just like it can with other medications. It is important to inform your healthcare provider about all the herbal products you are taking to evaluate potential interactions and ensure your safety during treatment.
Some Of tHe important Drug Connections with Resihance Tablet (Regorafenib)
Strong CYP3A4 Inhibitors/Inducers: Regorafenib is metabolized by the CYP3A4 enzyme, and concurrent use of strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin) or inducers (e.g., rifampin, carbamazepine) can alter the blood levels of Regorafenib. Inform your doctor about all medications, including prescription, over-the-counter, and herbal products, that you are currently taking.
Anticoagulants: The concurrent use of Regorafenib/Stivarga with anticoagulant medications, such as warfarin, may increase the risk of bleeding. Close monitoring of blood clotting parameters is necessary, and dosage adjustments of anticoagulants may be required.
Gastrointestinal Medications: Regorafenib (Resihance) can cause or worsen gastrointestinal side effects, such as diarrhea, nausea, and vomiting. The use of medications that can further increase the risk of these side effects, such as proton pump inhibitors or antiemetics, should be carefully considered.
| Manufacturer | : | Bayer Pharma, India |
| Equivalent Brand | : | Stivarga |
| Generic Search | : | Regorafenib |
